Emyria Ltd (EMD) - Total Liabilities
Based on the latest financial reports, Emyria Ltd (EMD) has total liabilities worth AU$1.31 Million AUD (≈ $929.05K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Emyria Ltd - Total Liabilities Trend (2018–2025)
This chart illustrates how Emyria Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Emyria Ltd to evaluate short-term liquidity relative to the company's equity base.
Emyria Ltd Competitors by Total Liabilities
The table below lists competitors of Emyria Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SMRT Holdings Bhd
KLSE:0117
|
Malaysia | RM16.64 Million |
|
Moong Pattana International Public Company Limited
BK:MOONG
|
Thailand | ฿309.17 Million |
|
Global Surfaces Limited
NSE:GSLSU
|
India | Rs2.70 Billion |
|
BG T&A Co
KQ:046310
|
Korea | ₩27.01 Billion |
|
Seker Finansal Kiralama AS
IS:SEKFK
|
Turkey | TL4.13 Billion |
|
Jullundur Motor Agency (Delhi) Limited
NSE:JMA
|
India | Rs749.82 Million |
|
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904
|
China | $614.48 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Emyria Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EMD company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Emyria Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Emyria Ltd (2018–2025)
The table below shows the annual total liabilities of Emyria Ltd from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$1.31 Million ≈ $929.05K |
-56.24% |
| 2024-06-30 | AU$3.00 Million ≈ $2.12 Million |
-10.98% |
| 2023-06-30 | AU$3.37 Million ≈ $2.38 Million |
+74.99% |
| 2022-06-30 | AU$1.93 Million ≈ $1.36 Million |
+2.37% |
| 2021-06-30 | AU$1.88 Million ≈ $1.33 Million |
+46.75% |
| 2020-06-30 | AU$1.28 Million ≈ $907.12K |
-57.62% |
| 2019-06-30 | AU$3.03 Million ≈ $2.14 Million |
+1108.07% |
| 2018-06-30 | AU$250.43K ≈ $177.19K |
-- |
About Emyria Ltd
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-… Read more